NASDAQ:FHTX

Foghorn Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy FHTX

*Your capital is at risk

$4.53

-0.210 (-4.43%)

At Close: Jul 31, 2026

Foghorn Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 96.46. In total, the insiders bought 11.53M and sold 1.22M FHTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	96.46
● Buy	11.53M shares
● Sell	1.22M shares
84% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jan 13, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 96.46. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (84% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 23, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	857 Value: $3K
Sep 23, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	857 Value: $3K
Sep 20, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	35 756 Value: $133.0K
Sep 20, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	35 756 Value: $133.0K
Sep 20, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	35 756 Value: $359.0K
Sep 20, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	35 756 Value: $359.0K
Sep 20, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	35 756 Value: $133.0K
Sep 20, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	35 756 Value: $133.0K
Sep 18, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	11 574 Value: $43.1K
Sep 18, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	11 574 Value: $43.1K
Sep 18, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	11 574 Value: $116.3K
Sep 18, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	11 574 Value: $116.3K
Sep 18, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	11 574 Value: $43.1K
Sep 18, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	11 574 Value: $43.1K
Sep 17, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	10 272 Value: $38.2K
Sep 17, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	10 272 Value: $38.2K
Sep 17, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	10 272 Value: $103.1K
Sep 17, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	10 272 Value: $103.1K
Sep 17, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	10 272 Value: $38.2K
Sep 17, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	10 272 Value: $38.2K
Sep 16, 2024 Buy	Stock Option (right to buy) M-Exempt	Costa Carlos Chief People Officer	Officer	400 Value: $1K
Sep 16, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	400 Value: $1K
Sep 16, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	400 Value: $4K
Sep 16, 2024 Sell	Common Stock S-Sale	Costa Carlos Chief People Officer	Officer	400 Value: $4K
Sep 16, 2024 Buy	Common Stock M-Exempt	Costa Carlos Chief People Officer	Officer	400 Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT FOGHORN THERAPEUTICS INC.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic...

Read Full Profile Here